Bibliografia
8.1 Cefalea indotta da uso o esposizione acuti a una sostanza
Altura BM, Altura BT, Gebrewold A.
Alcohol induced spasm of cerebral blood vessels. J Mental Sci 2000;104:972-999.
Armstrong, P.J. and A. Bersten (1986).
Normeperidine toxicity. Anesth Analg 65:536-538.
Ashina M, Bendtsen L, Jensen R, Olesen J.
Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000; 123: 1830-1837.
Askew GL, Finelli L, Genese CA, Sorhage FE, Sosin DM, Spitalny KC.
Bouillabaisse: an outbreak of methemoglobinemia in New Jersey in 1992. Pediatrics 94:381-384.
Askmark H, Lundberg PO, Olsson S.
Drug related headache. Headache 1989; 29:441-444.Atkins, F.M. (1986). A critical evaluation of clinical trials in adverse reactions to foods in adults. J Allergy Clin Immunol 78:174-182.
Atkins FM.
A critical evaluation of clinical trials in adverse reactions to foods in adults. J Allergy Clin Immunol 1986; 78:174–82.
Beck HG, Schulze WH, Suter GM.
Carbon monoxide-a domestic hazard. JAMA 1940; 115:1.
Bonnet GF, Nepveux P.
Migraine due to tyramine. Sem Hop 1971;Â 47:2441-2445.
Brewerton TD, Murphy DL, Lesem MD, Brandt HA, Jimerson DC.
Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache 1992; 32:217-22.
Catalano G, Catalano MC, Rodriguez R.
Dystonia associated with crack cocaine use. South Med J 1997; 90:1050-1052.
Cleophas TJ, Niemeyer MG, vander Wall EE, vander Meulen J.
Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dose. Angiology 1996; 47:679-685.
Council of Scientific Affairs.
Aspartame: review of safety issues. JAMA 1985; 254:400-402.
Cregler LL, Mark H.
Medical complications of cocaine abuse. N Engl J Med 1986; 15:1495-1501.
Dalton K.
Migraine and oral contraceptives. Headache 1976; 15: 247-251.
Dhopesh V, Maany I, Herring C.
The relationship of cocaine to headache in polysubstance abusers. Headache 1991; 31:17-19.
Dhuna A, Pascual-Leone A, Belgrade M.
Cocaine-related vascular headaches. J Neurol Neurosurg Psychiat 1991; 54: 803-6.
De Marinis M, Janiri L, Agnoli A.
Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 1991; 31: 159-163.
Ekbom K.
Nitroglycerin as a provocative agent in cluster headache. Arch Neurol 1968; 19:487-493.
el-Mallakh RS.
Marijuana and migraine. Headache 1987; 27:442-443.
el-Mallakh RS, Kranzler HR, Kamanitz JR.
Headaches and psychoactive substance use. Headache 1991; 31:584-587.
Forbes HS, Cobb S, Fremont-smith F.
Cerebral edema and headache following carbon monoxide asphyxia. Arch Neurol Psychiatr 1924; 11:164.
Gawin FH.
Cocaine addiction: psychology and neurophysiology. Science 1991; 251:1580-1586.
Ghose K, Carrol JD.
Mechanisms of tyramine-induced migraine: similarities with dopamine and interactions with disulfiram and propranolol. Neuropsychiobiol 1984; 12:122-126.
Gordon CR, Mankuta D, Shupak A, Spitzer O, Doweck I.
Recurrent classic migraine attacks following transdermal scopolamine intoxication. Headache 1991; 31:172-174.
Gore ME, Salmon PR.
Chinese restaurant syndrome: fact or fiction. Lancet 1980;318:251-2.
Hanington E, Harper AM.
The role of tyramine in the etiology of migraine and related studies on the cerebral and intracerebral circulations. Headache 1968; 8:84-97.
Hansen HJ, Drewes VM.
The nitroglycerine ointment test-a double-blind examination. Dan Med Bull 1970; 17:226-229.
Heckerling PS, Leikin JB , Maturen A, Perkins JT.
Predictors of occult carbon monoxide poisoning in patients with headache and dizziness. Ann Int Med 1987; 107: 174-176.
Henderson WR, Raskin NH.
"Hot dog" headache: individual susceptibility to nitrite. Lancet 1972; 2:1162-1163.
Hirsch, A.R., K.M. Rankin, and P.P. Panelli.
Trichloroethylene exposure and headache. Headache Quarterly 1996; 7:126-138.
Horowitz, L.D., M.V. Herman, and R. Gorlin.
Clinical response to nitroglycerine as a diagnostic test for coronary artery disease. Am J Cardiol 1972; 29:149-153.
Iversen HK, Nielsen TM, Olesen J, Tfelt-Hansen P.
Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 1989; 38: 17-24.
Kenney, R.A. and C.S. Tidball.
Human susceptibility to oral monosodium 1-glutamate. Am J Clin Nutr 1972; 25:140-146.
Kerr, G.R., M.W. Lee, M. elLozy, R. McGandy, and F. Stare.
Prevalence of the "Chinese restaurant syndrome". J Am Diet Assoc 1979; 75:29-33.
Krabbe, A.A. and J. Olesen.
Headache provocation by continuous intravenous infusion of histamine, clinical results and receptor mechanisms. Pain 1980; 8:253-259.
Larkin, J.M., G.J. Brahos, and J.A. Moylin.
Treatment of carbon monoxide poisoning: prognostic factors. J Trauma 1976; 16:111.
Lassen LH, Thomsen LL, Olesen J.
Histamine induces migraine via the H receptor. Support for the NO-hypothesis of migraine. Neuroreport 1995; 6: 1475-1479.
Leon, A.S., D.B. Hunninghake, C. Bell, D.K. Rassin, and T.R. Tephly.
Safety of long-term doses of aspartame. Arch Int Med 1989; 149:2318-2324.
Leone, M., A. Attanasio, D. Croci, G. Filippini, D. D'Amico, L. Grazzi, A. Nespolo, and G. Bussone.
The serotonergic agent m-chlorophenylpiperazine induced migraine attacks: a controlled study. Neurology 2000; 55:136-139.
Levine, S.R., J.C. Brust, N. Futrell, and et al.
Cerebrovascular complications of the use of the crack form of alkaloidal cocaine. N Engl J Med 1990; 323:699-704.
Lipton, R.B., C.M. Kwong, and S. Solomon.
Headaches in hospitalized cocaine users. Headache 1989;29:225-8.
Lowenstein, D.H., S.M. Massa, M.C. Rowbotham, and et al.
Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 1987; 83:841-846.
Luthy, J. and C. Schlatter.
Biogenic amines in food: effects of histamine, tyramine and phenylethylamine in the human. Z Lebensm Unters Forsch 1983; 177:439-443.
McCullock, J. and A.M. Harper.
Phenylethylamine and the cerebral circulation. In Current concepts in migraine research, (J. McCullock and A.M. Harper, eds.) pp. 85-88. Raven Press, 1978, New York.
Meigs, J.L. and J.P. Hughes.
Acute carbon monoxide poisoning: an analysis of 105 cases. AMA Arch Ind Hygiene Occupat Med 1952; 6:344-356.
Merkel, P.A., W.J. Koroshetz, M.C. Irizarry, and M.E. Cudkovicz.
Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 1995; 25:172-183.
Merrit, J.E. and P.B. Williams.
Vasospasm contributes to monosodium glutamate-induced headache. Headache 1990; 30:575-580.
Mitchell, J.D.
Clinical neurotoxicology: an introduction. In Handbook of clinical neurology, (F.A. DeWolff, ed.) pp. 1-22. Elsevier Science, 1995, pp. 1-22.
Moffet, A.M., M. Swash, and D.F. Scott.
Effect of chocolate in migraine: a double-blind study. J Neurol Neurosurg Psychiatry 1974; 7:445-448.
Monteiro, J.M.
Headache associated with single use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 715-720. Raven Press, Limited, 1993, New York.
Monteiro, J.M. and C.G. Dahlof.
Single use of substances. In The Headaches, (J. Olesen, P. Tfelt-Hansen, and K.M. Welch, eds.) pp. 861-869. Lippincott Williams & Wilkins, 2000, Philadelphia.
Murphree, A.B., L.A. Greenberg, and R.B. Carrol.
Neuropharmacologic effects of substances other than ethanol in alcoholic beverages. Fed Proc 1967; 26:1468-1473.
Nappi RE, A Cagnacci, F Granella, F Piccinini, F Polatti, F Facchinetti.
Course of primary headaches during hormone replacement therapy. Maturitas 2001; 38: 157-63.
Norton, S.
Toxicology of the central nervous system. In Toxicology, (L.J. Casarett and J. Doult, eds.) pp. 1019-1035. MacMillan, 1975, New York.
Ogata S, Hosoi T, Saji H.
Studies on acute alcohol intoxication. Japanese Journal of Studies of Alcohol 1966; 1: 67-79.
Peters, G.A.
Migraine: diagnosis and treatment with emphasis on the migraine-tension headache, provocative tests and use of rectal suppositories. Proc Mayo Clin 1953; 28:673-686.
Reif-Lehrer, L.
A questionnaire study of the prevalence of Chinese restaurant syndrome. Fed Proc 1977; 36:1617-1623.
Sabatini, U., O. Rascol, A. Rascol, and J.L. Montastruc.
Migraine attacks induced by subcutaneous apomorphine in two migrainous Parkinson Ian patients. Clin Neuropharmacol 1990; 13:264-267.
Satel, S.L. and F.H. Gawin.
Migraine-like headache and cocaine use. JAMA 1989; 261:2995-2996.
Schamburg, H.H., R. Byck, R. Gerstl, and J.H. Mashman.
Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science 1969; 163:826-828.
Scher, W. and B.M. Scher.
A possible role for nitric oxide in glutamate (MSG)-induced Chinese restaurant syndrome, glutamate induced asthma, "hot-dog headache", pugilistic Alzheimer's disease, and other disorders. Med Hypotheses 1992; 38:185-188.
Schiffmann, S.S., C.E. Buckley, H.A. Sampson, and et al.
Aspartame and susceptibility to headache. N Engl J Med 1987; 317:1181-1185.
Schnitker, M.T. and M.A. Schnitker.
Clinical notes, suggestions and new instruments. J Amer Med Assoc 1947; 135:89
Schwartz, A.M.
The cause, relief and prevention of headache arising from contact with dynamite. N Engl J Med 1946; 235:541-544.
Scopp, A.L.
MSG and hydrolyzed vegetable protein induced headache review and case studies. Headache 1991; 31:107-110.
Seltzer, S.
Foods and drug combinations, responsible for head and neck pain. Cephalalgia 1982; 2:111-124.
Shaw, S.W., R.H. Johnson, and H.G. Keogh.
Oral tyramine in dietary migraine sufferers. In Current concepts in migraine research, (S.W. Shaw, R.H. Johnson, and H.G. Keogh, eds.) pp. 31-39. Raven Press, 1978, New York.
Shively, M. and B. Riegel.
Effect of nitroglycerin ointment placement on headache and flushing in health subjects. Int J Nurs Stud 1991; 28:153-161.
Sicuteri, F., E.D. Bene, M. Poggioni, and A. Bonazzi.
Unmasking latent dysnociception in healthy subjects. Headache 1987; 27:180-185.
Smith, I., A.H. Kellow, and E. Hanington.
Clinical and biochemical correlation between tyramine and migraine headache. Headache 1970; 10:43-52.
Tarasoff, L. and M.F. Kelly.
Monosodium L-glutamate: a double-blind study and review. Food Chem Toxicol 1993; 31:1019-1035.
Thomsen LL, Kruse C, Iversen HK, Olesen J.
A Nitric oxide donor triggers genuine migraine attacks. Eur J Neurol 1994; 1: 71-80.
Towers, C.V., R.A. Pircon, M.P. Nageotte, M. Porto, and T.J. Garite.
Cocaine intoxication presenting as preeclampsia and eclampsia. Ob Gyn 1993; 81:545-547.
Trelles, L. and R. Jeri.
Central nervous system stimulants: cocaine, amphetamine, nicotine. In Handbook of clinical neurology, (F.A. DeWolff, ed.). New York: Elsevier Science, 1995: 251-7.
Wallgreen H, Barry A.
Drug actions in relation to alcohol effects. In: Action of alcohol. New York: Elsevier, 1970:621-714.
Wilson, J.
Cyanogenic glycosides. Ch. 3 in Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science, 1995: 25-34.
Varon J, Marik PE, Fromm RE, Gueler A.
Carbon Monoxide Poisoning: a review for clinicians. J. Emerg Med 1999; 17:87-93.
Yang, W.H., M.A. Drouin, M. Herbert, Y. Mao, and J. Kursh.
The monosodium glutamate symptom complex: assessment in a double blind, placebo controlled, randomized study. J Allergy Clin Immunol 1997; 99:757-762.
8.2 Cefalea da uso eccessivo di farmaci
Ala-Hurula, V., V. Myllyla, and E. Hokkanen.
Ergotamine abuse: results of ergotamine discontinuation with special reference to the plasma concentrations. Cephalalgia 1982; 2:189-195.
Ala-Hurula, V., V. Myllyla, E. Hokkanen, and O. Tokola.
Tolfenamic acid and ergotamine abuse. Headache 1981; 21:240-242.
Allgulander, C.
History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatr Scand 1986; 73:465-478.
Andersson, P.G.
Ergotamine headache. Headache 1975; 15:118-121.
Baar, H.A.
Treatment for headache: a four-step standardized withdrawal program for analgesic abusers. Pain Clin 1990; 3:173-177. (Abstract).
Bennett, W.M. and M.E. DeBroe.
Analgesic nephropathy: a preventable renal disease. N Eng J Med 1989; 320:1269-1271.
Bowdler, I., J. Killian, and S. Gänsslen-Blumberg.
The association between analgesic abuse and headache--coincidental or causal. Headache 1988;28:494.
Braithwaite RA.
The toxicity of tricyclic and newer antidepressants. In Handbook of Clinical Neurology, (F.A. DeWolff, ed.) pp. 311-320. New York: Elsevier Science 1995:311-20.
Brust, J.C.
Opiate addiction and toxicity. Ch. 16 in Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York: Elsevier Science, 1995, pp. 356-361.
Catarci, T., F. Fiacco, and C. Argentino.
Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 1994; 14:374-375.
Centonze, V., B.M. Polite, M. diBari, P. Caporaletti, and O. Albano.
Vascular injuries in ergotamine abuse: a case report. Funct Neurol 1993; 8:265-270.
Dalquen, P., J. Fasel, M.J. Mihatsch, M. Rist, and G. Rutishauser.
Phenacetinabusus IV. Sind zytologische harnuntersuchungen in der tumorvorsorge bei phenacetinabusern erfolgversprechend und anwendbar. Schweizerische Medizinische Wochenschrift 1980; 110:302-306.
DeBroe, M.E. and M.M. Elseviers.
Analgesic nephropathy--still a problem? Nephron 1993; 64:505-513.
deMarinis, M., L. Janiri, and A. Agnoli.
Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 1991; 31:159-163.
Diamond, S. and D.J. Dalessio.
Drug abuse in headache. In The practicing physician's approach to headache, (S. Diamond and D.J. Dalessio, eds.) pp. 114-121. Williams & Wilkins, 1982, Baltimore.
Dichgans, J. and H.C. Diener.
Clinical manifestations of excessive use of analgesic medication. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) pp. 8-15. Springer-Verlag, 1988, Berlin.
Dichgans, J., H.D. Diener, W.D. Gerber, and et al.
Analgetika-induzierter dauerkopfschmerz. Dtsch Med Wschr 1984; 109:369-73.
Diener, H.C.
A personal view of the classification and definition of drug dependence headache. Cephalalgia 1993; 13:68-71.
Diener, H.C. and C.G. Dahlof.
Headache associated with chronic use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 871-878. Lippincott, Williams & Wilkins, 1999, Philadelphia.
Diener, H.C., J. Dichgans, E. Scholz, S. Geiselhart, W.D. Gerber, and A. Bille.
Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989; 236:9-14.
Diener, H.C., J. Haab, C. Peters, S. Ried, J. Dichgans, and A. Pilgrim.
Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1991; 31:205-209.
Diener, H.C., V. Pfaffenrath, D. Soyka, and W.D. Gerber.
Therapie des medikamenten-induzierten dauerkopfschmerzes. Münch Med Wschr 1992; 134:159-162.
Diener, H.C. and P. Tfelt-Hansen.
Headache associated with chronic use of substances. In The headaches, (J. Olesen, P. Tfelt-Hansen, and K.M.A. Welch, eds.) pp. 721-727. Raven press LTD, 1993, New York.
Dige-Petersen, H., N.A. Lassen, J. Noer, K.H. Toennesen, and J. Olesen.
Subclinical ergotism. Lancet 1977;Â i:65-66.
Drucker, P. and S. Tepper.
Daily sumatriptan for detoxification from rebound. Headache 1998; 38:687-690.
Dubach, U.C., B. Rosner, and E. Pfister.
Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med 1983; 308:357-362.
Elkind, A.H.
Drug abuse in headache patients. Clin J Pain 1989; 5:111-120.
Elkind, A.H.
Drug abuse and headache. Med Clin N Am 1991; 75:717-732.
Evers, S., I. Gralow, B. Bauer, B. Suhr, A. Buchheister, I.W. Husstedt, and E.B. Ringelstein.
Sumatriptan and ergotamine overuse and drug-induced headache: a clinicoepidemiologic study. Clin Neuropharmacol 1999; 22:201-206.
Fanciullaci, M., M. Alessandri, U. Pietrini, E. Briccolani-Bandini, and S. Beatrice.
Long-term ergotamine abuse: effect on adrenergically induced mydriasis. Clin Pharm Ther 1992; 51:302-307.
Fincham, J.E.
Over-the-counter drug use and misuse by the ambulatory elderly: a review of the literature. J Ger Drug Ther 1987; 1:3-21.
Fincham, R.W., Z. Perdue, and V.D. Dunn.
Bilateral focal cortical atrophy and chronic ergotamine abuse. Neurology 1985; 35:720-722.
Fisher, C.M.
Analgesic rebound headache refuted. Headache 1988; 28:666.
Friedman, A.P., P. Brazil, and T.J. vonStorch.
Ergotamine tolerance in patients with migraine. JAMA 1955; 157:881-884.
Gaist, D., J. Hallas, S.H. Sindrup, and L.F. Gram.
Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 1996; 50:161-165.
Gaist, D., I. Tsiropoulus, S.H. Sindrup, J. Hallas, B.K. Rasmussen, and J. Kragstrup.
Inappropriate use of sumatriptan: population based register and interview study. Br J Med 1998; 316:1352-1353.
Granella, F., S. Farina, G. Malferrari, and G.C. Manzoni.
Drug abuse in chronic headache: a clinicoepidemiologic study. Cephalalgia 1987; 7:15-19.
Gutzwiller, F. and E. Zemp.
Der analgetikakonsum in der bevölkerung und socioökonomische aspekte des analgetikaabusus. In Das analgetikasyndrom, (M.J. Mihatsch, ed. ) Thieme, Stuttgart. 1986, pp. 197-205.
Hering, R. and T.J. Steiner.
Abrupt outpatient withdrawal from medication in analgesic-abusing migraineurs. Lancet 1991; 337:1442-1443.
Hokkanen, E., O. Waltimo, and T. Kallanranta.
Toxic effects of ergotamine used for migraine. Headache1978; 18:95-98.
Horowski, R. and A. Ziegler.
Possible pharmacological mechanisms of chronic abuse of analgesics and other antimigraine drugs. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds. ) Springer-Verlag, Berlin. 1988, pp. 95-104.
Horton, B.T. and G.A. Peters.
Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1963; 3:214-226.
Isler, H.
Migraine treatment as a cause of chronic migraine. In Advances in migraine research and therapy, (F.C. Rose, ed.) Raven Press, New York. 1982, pp. 159-164.
Jaffe, J.H.
Drug addiction and drug abuse. In The pharmacological basis of therapeutics, (A.G. Gilman, T.W. Rall, A.S. Nies, and P. Taylor, eds. ) Pergamon Press, New York. 1985, pp. 522-573.
Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V.
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57:1694-1698.
Kaube, H., A. May, H.C. Diener, and V. Pfaffenrath.
Sumatriptan misuse in daily chronic headache. Br Med J 1994; 308:1573.
Kielholz, P. and D. Ladewig.
Probleme des medikamentenmi beta-brauches. Schweiz Ärztezeitung 1981; 62:2866-2869.
Klapper, J.A.
Rebound headache: definition, symptomatology, treatment, and prevention. Headache Quarterly 1992; 3:398-402.
Kouyanou, K., C.E. Pither, S. Rabe-Hesketh, and S. Wessely.
A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically explained symptoms. Pain 1998; 76:417-426.
Kudrow, L.
Paradoxical effects of frequent analgesic use. Adv Neurol 1982; 33:335-341.
Lader M.
Hypnotics and sedatives. In Handbook of clinical neurology, (F.A. DeWolff, ed.). New York, Elsevier Science, 1995, pp. 329-55.
Lance, F., C. Parkes, and M. Wilkinson.
Does analgesic abuse cause headache de novo? Headache 1988; 28:61-62.
Lance, J.W.
A concept of migraine and the search for the ideal headache drug. Headache 1990; 30:17-23.
Limmroth, V., S. Kazarawa, G. Fritsche, and H.C. Diener.
Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 1999; 353:378.
Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC.
Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-1014.
Lucas, R.N. and W. Falkowski.
Ergotamine and methysergide abuse in patients with migraine. Br J Psychiatry 1973; 122:199-203.
Ludolph, A.C., I.W. Husstedt, H.P. Schlake, K.H. Grotemeyer, and G.G. Brune.
Chronic ergotamine abuse: evidence of functional impairment of long ascending spinal tracts. Eur Neurol 1988; 28:311-316.
MacGregor, E.A., C. Vorah, and M. Wilkinson.
Analgesic use: a study of treatments used by patients for migraine prior to attending the City of London migraine clinic. Headache 1990; 30:634-638.
Manzoni, G.C., G. Micieli, F. Granella, G. Sandrini, C. Zanferrari, and G. Nappi.
Therapeutic approach to drug abuse in headache patients. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) Springer-Verlag, Berlin. 1988, pp. 143-149.
Marks, V.
Reactive (rebound) hypoglycemia). In Hypoglycemia, (V. Marks and C.F. Rose, eds.) Blackwell, Oxford. 1981, pp. 179-217.
Mathew, N.T.
Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 1987; 27:130-133.
Mathew, N.T., R. Kurman, and F. Perez.
Drug induced refractory headache - clinical features and management. Headache 1990; 30:634-638.
Michultka, D.M., E.B. Blanchard, K.A. Appelbaum, J. Jaccard, and M.P. Dentinger.
The refractory headache patient--2. High medication consumption (analgesic rebound) headache. Behav Res Ther 1989; 27:411-420.
Micieli, G., G.C. Manzoni, F. Granella, E. Martignoni, G. Malferrari, and G. Nappi.
Clinical and epidemiological observations on drug abuse in headache patients. In Drug-Induced Headache, (H.C. Diener and M. Wilkinson, eds.)Â Springer-Verlag, Berlin. 1988, pp. 20-28.
Nicolodi, M., P.L. DelBianco, and F. Sicuteri.
The way to serotonergic use and abuse in migraine. Int J Clin Pharmacol Res 1997; 17:79-84.
Page, H.
Rebound headache from ergotamine withdrawal. JAMA 1981; 246:719.
Peters, G. and B.T. Horton.
Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Mayo Clin 1951; 26:153-161.
Pini, L.A. and T. Trenti.
Case report: does chronic use of sumatriptan induce dependence? Headache 1994; 34:600-601.
Pradalier, A., S. Dry, and J.F. Baron.
Cephalée induite par l'abuse de tartrate d'ergotamine chez les migrainieux. Concours Méd 1984; 106:106-110.
Rahman, A., M. Segasothy, S.A. Samad, A. Zulfiqar, and M. Rani.
Analgesic use and chronic renal disease in patients with headache. Headache 1993; 33:442-445.
Rapoport, A., P. Stang, D.L. Gutterman, R. Cady, H. Markley, R. Weeks, J. Saiers, and A.W. Fox.
Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996; 36:14-19.
Rapoport, A.M.
Analgesic rebound headache. Headache 1988; 28:662-665.
Rapoport, A.M. and R.E. Weeks.
Characteristics and treatment of analgesic rebound headache. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) Springer-Verlag, Berlin. 1988, pp. 162-167.
Roswell, A.R., C. Neylan, and M. Wilkinson.
Ergotamine induced headache in migrainous patients. Headache 1973; 13:65-67.
Sandler, D.P., J.C. Smith, C.R. Weinberg, V.M. Buckalew, V.W. Dennis, W.B. Blythe, and W.P. Burgess.
Analgesic use and chronic renal disease. N Engl J Med 1989; 320:1238-1243.
Saper, J.R.
Drug abuse among headache patients. In Headache disorders, (J.R. Saper, ed.) PSG Publishers, Boston. 1983, pp. 263-278.
Saper, J.R.
Drug overuse among patients with headache. Neurol Clin 1983; 1:465-477.
Saper, J.R.
Daily chronic headaches. Neurol Clin N Amer 1990; 8:891-902.
Saper, J.R. and J.M. Jones.
Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 1986; 9:244-256.
Schnider, P., S. Aull, C. Baumgartner, and et al.
Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year followup. Cephalalgia 1996; 16:481-485.
Schnider, P., S. Aull, and M. Feucht.
Use and abuse of analgesics in tension-type headache. Cephalalgia 1994; 14:162-167.
Schnider, P., J. Maly, J. Grunberger, S. Aull, K. Zeiler, and P. Wessely.
Improvement of decreased critical flicker frequency in headache patients with drug abuse after successful withdrawal. Headache 1995; 35:269-272.
Schoenen, J., P. Lenarduzzi, and J. Sianard-Gainko.
Chronic headaches associated with analgesics and/or ergotamine abuse: a clinical survey of 434 consecutive outpatients. In New advances in headache research, (F.D. Rose, ed.) Smith-Gordon, London. 1989, pp. 29-43.
Seller, E.M., U.E. Busto, H.L. Kaplan, G. Somer, and G.J. Baylon.
Comparative abuse liability of codeine and naratriptan. Clin Pharmacol Ther 1998; 63:121.
Shakir, R.A.
Vitamin toxicity. In Handbook of clinical neurology, vol. 65 (F.A. DeWolff, ed.). New York, Elsevier Science. 1995, pp. 567-576.
Silberstein, S.D. and R.B. Lipton.
Chronic daily headache. In Headache, (P.J. Goadsby and S.D. Silberstein, eds.)Â Butterworth-Heinemann, Newton. 1997, pp. 201-225.
Silberstein, S.D., R.B. Lipton, S. Solomon, and N.T. Mathew.
Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 1994; 34:1-7.
Silberstein, S.D. and J.R. Silberstein.
Chronic daily headache: prognosis following inpatient treatment with repetitive IV DHE. Headache 1992; 32:439-445.
Stewart, J.H.
Analgesic abuse and renal failure in Australia. Kidney International 1978; 13:72-78.
Sullivan, J.T. and E.M. Sellers.
Treatment of the barbiturate abstinence syndrome. Med J Aust 1986; 145:456-458.
Taschner, K.L. and G.A. Wiesbeck.
Psychiatric aspects of drug addiction of the barbiturate-alcohol type. In Drug-induced headache, (H.C. Diener and M. Wilkinson, eds.) Berlin, Springer-Verlag. 1988, pp. 80-84.
Tfelt-Hansen, P.
Ergotamine headache. In Updating in headache, (V. Pfaffenrath, P. Lundberg, and O. Sjaastad, eds.) Springer, Berlin. 1985, pp. 169-172.
Tfelt-Hansen, P.
The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol 1986; 59:1-29.
Tfelt-Hansen, P. and A.A. Krabbe.
Ergotamine. Do patients benefit from withdrawal? Cephalalgia 1981; 1:29-32.
Tfelt-Hansen, P. and J. Olesen.
Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Acta Physiol Scand 1981; 48:69-72.
Tfelt-Hansen, P. and L. Paalzow.
Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther 1985; 37:29-35.
Tfelt-Hansen, P., P.R. Saxena, and M.D. Ferrari (1995).
Ergot alkaloids. In Handbook of clinical neurology, (F.A. DeWolff, ed.) New York, Elsevier Science. 1995, pp. 61-67.
Timmings, P.L. and A. Richens (1995).
Neurotoxicology of antiepileptic drugs. In Handbook of clinical neurology, (F.A. DeWolff, ed.) New York: Elsevier Science. 1995, pp. 495-513.
Vasconcellos, E., J.E. Pina-Garza, E.J. Millan, and J.S. Warner.
Analgesic rebound headache in children and adolescents. J Child Neurol 1998; 13:443-447.
Verhoeff, N.P., W.H. Visser, M.D. Ferrari, P.R. Saxena, and E.A. vonRoyen.
Dopamine D2 receptor imaging with 123-I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier. Cephalalgia 1993; 13:325-329.
VonKorff, M., B.S. Galer, and P. Stang.
Chronic use of symptomatic headache medications. Pain 1995; 62:179-186.
Walker, J., S. Parisi, and D. Olive.
Analgesic rebound headache: experience in a community hospital. Southern Med J 1993; 86:1202-1205.
Warner, J.S.
Rebound headaches: a review. Headache Quarterly 1999; 10:207-219.
Zed, P.J., P.S. Loewen, and G. Robinson.
Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 1999; 33:61-72.
Ziegler, D.K.
Opiate and opioid use in patients with refractory headache. Cephalalgia 2000; 14:5-10.
8.3 Cefalea come evento avverso attribuito all’uso cronico di farmaci
de Lignières B, Silberstein SD.
Pharmacodynamics of oestrogens and progestagens. Cephalalgia 2000;20:200-207.
Silberstein SD.
Hormone-related headache. M Clin N Am 2001;85:1017-1035.
Silberstein SD, de Lignières B.
Migraine, menopause and hormonal replacement therapy. Cephalalgia 2000;20:214-212.
8.4 Cefalea attribuita a sospensione di sostanze
Abbott, P.J.
Caffeine: a toxicological overview. Med J Aust 1986; 145:518-521.
Baumgartner, G.R. and R.C. Rowen.
Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 1991; 84:312-321.
Dalessio, D.J. (1980).
Wolff's headache and other head pain, Oxford University Press, Oxford.
Epstein MT, JM Hockaday, TDR Hockaday.
Migraine and reproductive hormones through the menstrual cycle. Lancet 1975; i:543-548.
Greden, J.F., M. Fontaine, M. Lubetsky, and K. Chamberlin.
Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatr 1978; 135:963-966.
Laska, E.M., A. Sunshine, F. Mueller, W.B. Elvers, C. Siegel, and A. Rubin.
Caffeine as an analgesic adjuvant. JAMA 1984; 251:1711-1718.
Lichten E, J Lichten, A Whitty, D Pieper.
The confirmation of a biochemical marker for women's hormonal migraine : the depo-oestradiol challenge test. Headache 1996; 36: 367-71.
Raskin, N.H. and O. Appenzeller.
Headache. Saunders, Philadelphia. 1980
Silverman, K., S.M. Evans, E.C. Strain, and R.R. Griffiths.
Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Eng J Med 1992; 327:1109-1114.
Somerville B.
Estrogen withdrawal migraine. Neurology 1975; 25: 239-250.
vanDusseldorp, M. and M.B. Katan.
Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br Med J 1990; 300:1558-1559.
White, B.C., C.A. Lincoln, N.W. Pearcz, R. Reeb, and C. Vaida.
Anxiety and muscle tension as consequence of caffeine withdrawal. Science 1980; 209:1547-1548.
